| RS1553437028 |
TMEM127
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1553437083 |
RAB3GAP1
|
Health Risk |
Pathogenic |
Martsolf syndrome, Martsolf syndrome 2 |
| RS1553437737 |
TMEM127
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1553437759 |
TMEM127
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS1553442237 |
CKAP2L
|
Health Risk |
Pathogenic |
Filippi syndrome, Filippi syndrome |
| RS1553443360 |
EDAR
|
Health Risk |
Pathogenic |
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type |
| RS1553444644 |
RAB3GAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Warburg micro syndrome 1, Warburg micro syndrome 1 |
| RS1553444895 |
EDAR
|
Health Risk |
Pathogenic |
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type |
| RS1553444917 |
EDAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Autosomal recessive hypohidrotic ectodermal dysplasia syndrome |
| RS1553445945 |
EDAR
|
Health Risk |
Likely pathogenic |
Ectodermal dysplasia, Ectodermal dysplasia |
| RS1553445966 |
EDAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553446603 |
NCAPH
|
Health Risk |
Pathogenic |
Microcephaly 23, primary |
| RS1553447991 |
CNGA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia, Achromatopsia 2 |
| RS1553448320 |
EDAR
|
Health Risk |
Pathogenic |
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type |
| RS1553448527 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553449159 |
GLI2
|
Health Risk |
Likely pathogenic |
— |
| RS1553449458 |
MERTK
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 38, Retinitis pigmentosa 38 |
| RS1553450734 |
CNGA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia, Achromatopsia |
| RS1553450762 |
CNGA3
|
Health Risk |
Pathogenic |
Achromatopsia 2, Achromatopsia 2 |
| RS1553450764 |
CNGA3
|
Health Risk |
Pathogenic |
Achromatopsia, Achromatopsia |
| RS1553450895 |
CNGA3
|
Health Risk |
Likely pathogenic |
— |
| RS1553450979 |
CNGA3
|
Health Risk |
Likely pathogenic |
— |
| RS1553452169 |
MERTK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1553453324 |
RYR2
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553453398 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553453945 |
MMADHC
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic aciduria and homocystinuria type cblD, MMADHC-related disorder |
| RS1553454436 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS1553454799 |
MERTK
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 38, Retinitis pigmentosa 38 |
| RS1553454821 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1553456695 |
NR4A2
|
Health Risk |
Likely pathogenic |
Epilepsy, Epilepsy |
| RS1553457607 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553458019 |
BIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, centronuclear |
| RS1553458060 |
MERTK
|
Health Risk |
Likely pathogenic |
— |
| RS1553458124 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553459020 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aicardi-Goutieres syndrome 7, Singleton-Merten syndrome 1 |
| RS1553461156 |
REEP1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 31, Hereditary spastic paraplegia 31 |
| RS1553461660 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553461662 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1553461665 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1553461672 |
SCN2A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1553462132 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553462134 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553462203 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS1553462224 |
SCN2A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1553462227 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial infantile |
| RS1553462741 |
REEP1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 31, Hereditary spastic paraplegia 31 |
| RS1553463032 |
SCN2A
|
Health Risk |
Pathogenic |
SCN2A-related disorder, Complex neurodevelopmental disorder |
| RS1553463038 |
SCN2A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Benign familial infantile epilepsy |
| RS1553463042 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS1553463074 |
SCN2A
|
Health Risk |
Pathogenic |
— |
| RS1553463096 |
SCN2A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, SCN2A-related disorder |
| RS1553463119 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial infantile |
| RS1553463140 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS1553463427 |
SCN2A
|
Health Risk |
Pathogenic |
Episodic ataxia, type 9 |
| RS1553463464 |
SCN2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553463513 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial infantile |
| RS1553463516 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1553463586 |
SCN2A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553463594 |
SCN2A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1553463602 |
SCN2A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1553463634 |
SCN2A
|
Health Risk |
Pathogenic |
— |
| RS1553463635 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553463649 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553463676 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizure, Developmental and epileptic encephalopathy |
| RS1553463718 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial infantile |
| RS1553463764 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS1553463772 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1553463775 |
SCN2A
|
Health Risk |
Likely pathogenic |
Marfanoid habitus and intellectual disability, Marfanoid habitus and intellectual disability |
| RS1553463778 |
KIF5C
|
Health Risk |
Pathogenic/Likely pathogenic |
Complex cortical dysplasia with other brain malformations 2, Complex cortical dysplasia with other brain malformations 2 |
| RS1553463850 |
SCN2A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553466082 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS1553466434 |
DCTN1
|
Health Risk |
Pathogenic |
Neuronopathy, distal hereditary motor |
| RS1553466489 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS1553468235 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Benign recurrent intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS1553468939 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553468960 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553469070 |
CHRNA1
|
Health Risk |
Likely pathogenic |
— |
| RS1553469156 |
SLC25A12
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 39 |
| RS1553469502 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553469514 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553469602 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS1553471273 |
GLI2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS1553472127 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553472910 |
SCN9A
|
Health Risk |
Likely pathogenic |
— |
| RS1553473041 |
SCN9A
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS1553473186 |
SCN9A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 7 |
| RS1553474394 |
SCN9A
|
Health Risk |
Pathogenic |
Paroxysmal extreme pain disorder, Paroxysmal extreme pain disorder |
| RS1553474406 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuropathy, hereditary sensory and autonomic |
| RS1553474576 |
CNNM4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1553475005 |
CHN1
|
Health Risk |
Pathogenic |
Duane retraction syndrome 2, Duane retraction syndrome 2 |
| RS1553476382 |
GLI2
|
Health Risk |
Pathogenic/Likely pathogenic |
Holoprosencephaly 9, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS1553476928 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1553477189 |
GLI2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553477432 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1553478042 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553478423 |
GLI2
|
Health Risk |
Pathogenic |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS1553478584 |
SCN9A
|
Health Risk |
Pathogenic |
Channelopathy-associated congenital insensitivity to pain, autosomal recessive |
| RS1553479210 |
SCN9A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS1553479216 |
SCN9A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Neuropathy |
| RS1553479405 |
GLI2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |